GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$454M
AUM Growth
+$70.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$18.9M
2
+$17.6M
3
+$14.4M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$13.8M
5
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$10.4M

Top Sells

1
+$17.1M
2
+$11.1M
3
+$8.82M
4
PLXP
PLx Pharma Inc. Common Stock
PLXP
+$2.59M
5
PDLI
PDL BioPharma, Inc.
PDLI
+$2.16M

Sector Composition

1 Healthcare 87.1%
2 Technology 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$44M 9.03%
2,601,351
2
$33.3M 6.84%
3,000,000
+230,575
3
$32.1M 6.59%
2,010,000
-696,134
4
$30.3M 6.22%
4,973,509
-1,448,723
5
$29.7M 6.09%
2,440,959
6
$29M 5.96%
750,000
+355,920
7
$27.7M 5.7%
828,253
+38,253
8
$21.2M 4.36%
4,000,000
+524,773
9
$20.4M 4.19%
635,500
+325,102
10
$19.7M 4.05%
413,179
+32,084
11
$19.7M 4.05%
385,683
+120,790
12
$18.9M 3.88%
+65,520
13
$17.6M 3.62%
+4,801
14
$15.9M 3.27%
437,865
+37,865
15
$14.4M 2.97%
+1,000,000
16
$13M 2.67%
37,000
+23,855
17
$11M 2.25%
3,055,000
+375,000
18
$9.15M 1.88%
375,000
+351,481
19
$7.79M 1.6%
+270,000
20
$6.93M 1.42%
4,127,232
21
$5.57M 1.14%
43,939
+13,551
22
$4.35M 0.89%
+350,000
23
$4.13M 0.85%
870,261
+642,604
24
$4.12M 0.85%
1,963,777
25
$3.46M 0.71%
114,080
-565,323
1
2